These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20562395)

  • 1. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: similarities in a TARDBP-linked ALS patient.
    Hernandez Lain A; Millecamps S; Dubourg O; Salachas F; Bruneteau G; Lacomblez L; LeGuern E; Seilhean D; Duyckaerts C; Meininger V; Mallet J; Pradat PF
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1414-6. PubMed ID: 20562395
    [No Abstract]   [Full Text] [Related]  

  • 2. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.
    Lattante S; Rouleau GA; Kabashi E
    Hum Mutat; 2013 Jun; 34(6):812-26. PubMed ID: 23559573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.
    Cykowski MD; Powell SZ; Appel JW; Arumanayagam AS; Rivera AL; Appel SH
    Acta Neuropathol Commun; 2018 Apr; 6(1):28. PubMed ID: 29653597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of amyotrophic lateral sclerosis.
    Liscic RM; Breljak D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.
    DeJesus-Hernandez M; Kocerha J; Finch N; Crook R; Baker M; Desaro P; Johnston A; Rutherford N; Wojtas A; Kennelly K; Wszolek ZK; Graff-Radford N; Boylan K; Rademakers R
    Hum Mutat; 2010 May; 31(5):E1377-89. PubMed ID: 20232451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ; Volkening K
    FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 and FUS: a nuclear affair.
    Dormann D; Haass C
    Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
    Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 and FUS/TLS yield a target-rich haul in ALS.
    Gitler AD
    Nat Neurosci; 2012 Nov; 15(11):1467-9. PubMed ID: 23103989
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
    Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
    Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria and ALS: implications from novel genes and pathways.
    Cozzolino M; Ferri A; Valle C; Carrì MT
    Mol Cell Neurosci; 2013 Jul; 55():44-9. PubMed ID: 22705710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease.
    Ito H; Fujita K; Nakamura M; Wate R; Kaneko S; Sasaki S; Yamane K; Suzuki N; Aoki M; Shibata N; Togashi S; Kawata A; Mochizuki Y; Mizutani T; Maruyama H; Hirano A; Takahashi R; Kawakami H; Kusaka H
    Acta Neuropathol; 2011 Apr; 121(4):555-7. PubMed ID: 21327942
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis.
    Verma A
    Neurol India; 2013; 61(2):107-10. PubMed ID: 23644307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
    Wang XN; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
    Fiesel FC; Kahle PJ
    FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From nucleation to widespread propagation: A prion-like concept for ALS.
    Maniecka Z; Polymenidou M
    Virus Res; 2015 Sep; 207():94-105. PubMed ID: 25656065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.